Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

European Commission approves Cablivi for acquired thrombotic thrombocytopenic purpura

Sep. 3, 2018

FDA approves Jivi for hemophilia A

Aug. 31, 2018

Sangamo reports positive preliminary data from Alta study of gene therapy for hemophilia A

Aug. 9, 2018

TiumBio presents preclinical data for NBP-604, a new fusion protein for hemophilia

Aug. 3, 2018

Asahi Kasei presents preliminary results of SCARLET phase III trial of ART-123

Aug. 3, 2018

Shionogi's Mulpleta wins approval in the U.S.

Aug. 2, 2018

First-in-human data presented for AB-023

July 31, 2018

Researchers develop CD41-KO murine model of immune thrombocytopenia

July 27, 2018

New method to up fetal hemoglobin

July 26, 2018

Epizyme discovers EHMT1 and/or EHMT2 inhibitors

July 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...